Swedbank AB »

Crinetics Pharmaceuticals In shares owned by Swedbank AB

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Swedbank AB from 13F filings

Historical chart of Swedbank AB investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Swedbank AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Swedbank AB

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.2M 60k 37.42

More positions owned by Swedbank AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Kla Corp Com New (KLAC)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)

View all positions for Swedbank AB

Top funds holding Crinetics Pharmaceuticals In

FMR
BlackRock
Farallon Capital Management
Wellington Management Company
Driehaus Capital Management
T. Rowe Price Associates
Vanguard Portfolio Management
Vanguard Capital Management
Jupiter Topco
Henderson Group
Geode Capital Management
Bellevue Group
State Street Corporation
Baker Bros. Advisors
Polar Capital Holdings

View all funds holding Crinetics Pharmaceuticals In